The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.80
Bid: 33.00
Ask: 34.60
Change: -0.20 (-0.59%)
Spread: 1.60 (4.848%)
Open: 34.00
High: 34.00
Low: 33.80
Prev. Close: 34.00
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

30 Jul 2009 07:00

RNS Number : 5296W
Merchant Securities PLC
30 July 2009
 



News release

30 July 2009

Merchant Securities plc

Final results for the year ended 31 March 2009

Merchant Securities plc ("the Group"), the financial services group specialising in institutional research and tradingprivate client investment management, corporate finance and corporate broking announces its final results for the year ended 31 March 2009.

Financial and operational highlights:

Company continues to weather financial crisis and is emerging stronger and capable of capitalising on opportunities presented by the current economic environment

Pre-tax profit in second half of £79,000 reduces loss for the year ended 31 March 2009, to £502,000 before non-recurring investment writedowns of £396,000, together with a write-down of intangible assets of £646,700 and goodwill of £2,624,000

Business review has eliminated excess costs and focused business on core activities of private client investment services, institutional research and trading, corporate finance for public and private companies and corporate broking

Group reorganisation to transfer the business of Merchant Securities Group Limited ("MSGL"), into John East & Partners Limited, ("JEP") as the single entity which will carry out all the activities currently conducted within the group. The name of the trading subsidiary will be Merchant John East Securities Limited

Since the year end, our institutional, private client wealth management and contracts for difference business activities continue to grow and the Group has made a profit before and after taxation in the first quarter of 2009-10

John Green, Chairman, Merchant Securities plc, says:

"A year ago we were entering the eye of the storm and it would be folly to suggest that the coming year will be anything other than difficult. With the private client division's continued issue of innovative structured investment products, a full year's contribution from Mercantalyst, the prospects of an improvement in corporate finance activity and the cost efficiencies arising from the reorganisation, I am confident that the Board and senior management have taken the right action to position the Company to deliver value to shareholders. It is also pleasing to note that the Group has made a profit before taxation in the first quarter of the current financial year."

For further information please contact:

Patrick Claridge Chief Executive 020 7375 9010

John Foster-Powell Chief Financial Officer

Merchant Securities plc

Roland Cross/Emma Murphy 020 7726 6111

Broadgate

Richard Day/Matthew Armitt 020 7398 1600

Arden Partners plc

The Company has convened its fourth Annual General Meeting to be held at John Stow House, 18 Bevis Marks, London EC3A 7JB on 23 September 2009, at 10.00 am.

Financial statements for the year ended 31 March 2009 will be posted to shareholders by 28 August 2009 who are on the register on 18 August 2009 and will also available from the Company's registered office, John Stow House, 18 Bevis Marks, London EC3A 7JB. Alternatively, the document will be available to be viewed or downloaded from the Company's website: www.merchantsecurities.co.uk

CHAIRMAN'S STATEMENT

Introduction

In presenting our results for the year ended 31 March 2009, I am pleased to report that, notwithstanding the turmoil in financial markets, Merchant Securities has made significant progress, both financially and in the development of its strategy.

Decisive action by the board enabled the Company to turn around performance in the second half, so earning a small pre tax profit in that period. The Company has thus not only weathered the financial crisis, but emerged stronger and capable of capitalising on the opportunities that are likely to materialise in the current trading environment.

The Group earned a pre-tax profit in the second half of £79,000 before goodwill impairment, revaluation of investments and non-recurring items. The costs of reorganising the business and difficult market conditions for the year ended 31 March 2009 resulted, however, in a pre-tax loss for the year as a whole of £502,000 on the same basis.

The Board has reviewed the goodwill and intangible assets carried on its balance sheet in accordance with International Financial Reporting Standards. Following this review, the Board has decided to take a charge of £647,000 for the impairment of intangible assets and a further charge of £2,624,000 relating to the impairment of goodwill. Neither of these amounts has any impact on the Group's financial position, tangible net assets, cash balances or regulatory capital. Your Board has decided to take this approach to reflect the changed market conditions currently prevalent and which impact the main operating subsidiaries of the Company.

Strategic development

I referred in my statement last year to the need to focus and develop our core activities as well as to strengthen the infrastructure of the business. The Group strengthened its balance sheet in June 2008 through the issue of new share capital. Patrick Claridge, formerly the chief operating officer, was appointed chief executive in August 2008. He has instigated a review of the business which has led to an elimination of excess costs and an increased focus on core activities, namely private client investment services, institutional research and trading, corporate finance for public and private companies and corporate broking.

The Company has no debt and a strengthened balance sheet. The board, therefore, believes that the Company is well placed to exploit the current market conditions, which it believes may present opportunities for organic growth and growth through carefully targeted acquisitions or appointments. Each of the Company's core activities is charged with the objective of growing its business and achieving recurring revenue streams.

The Board intends to transfer the business of MSGL into JEP which will become the single entity carrying out all the activities currently conducted within the group. The name of the trading subsidiary will be Merchant John East Securities Limited and it is intended that the process will be completed by 30 September 2009. Apart from establishing a single brand, the reorganisation will bring further cost savings and streamline the Company's structure by removing duplication of finance and compliance functions.

Operational and financial review

We announced in April that the Company expected to make a modest profit in the second half of the year and, on the basis set out above, this was achieved. For the year ended 31 March 2009, the Company made a pre tax loss of £4,577,000 on turnover of £5,425,000. As also set out above, the Group made a loss of £502,000 before goodwill impairment, revaluation of investments and non-recurring items. A profit was made in the second half of the year of £79,000 on the same basis. The non-recurring losses of £4,074,000, relate to the costs of reorganising the group, continuing amortisation of the intangible asset arising from the acquisition of JEP, an additional write-down of intangible assets and goodwill, together with the impact of a decision at the half year to write down all of the Company's investments to nil.

Following the write-down of our investment portfolio in the first half and the decision to write-down the goodwill and intangible assets there were no other exceptional items in the second half. As at 31 March 2009, the Company had net tangible assets of £2.9 million, cash of £2.2 million and no debt. The directors believe that the Company has a comfortable capital cushion over its minimum regulatory capital requirement.

Current trading

I have spoken before of the Board's strategy of developing a diversified financial services group and over recent months we have further enhanced the range of services, products and expertise within various core areas of the Company.

The institutional business has been substantially enhanced by its daily research product, Mercantalyst. This is a strongly differentiated publication which is received by an ever expanding list of institutional clients and is generating worthwhile and growing revenue.

Since the year end, the volumes in our private client wealth management and contracts for difference business have continued to grow. JEP had 38 retained clients at the year end and whilst there is little IPO activity, it continues to receive income from retainers, secondary issues and general advisory work. The private equity team continues to raise funds for private companies in the sub £10 million sector.

Within the private client business, we are looking for ways to differentiate ourselves from our competitors. This has been achieved through the issue of various structured investment products designed to manage current market risk. These have been well received by clients.

Current year trading has continued to improve and the group has made a modest profit before and after taxation in the first quarter of 2009-10

Board changes

John Foster-Powell was appointed to the board on 10 November 2008 as Chief Financial Officer.

Outlook

A year ago we were entering the eye of the storm and it would be folly to suggest that the coming year will be anything other than difficult. The progress made over the last year has, however, been heartening and I would like to express my thanks to Patrick, the senior management team and all members of staff who have worked hard and successfully in very tough conditions. It is particularly pleasing to note that the Group has started the first quarter of the current financial year with a modest profit before taxation.

With the private client division's continued issue of innovative structured investment products, a full year's contribution from Mercantalyst, the prospects of an improvement in corporate finance activity and the cost efficiencies arising from carrying on all trading within one entity, I am confident that the Board and senior management have taken the right action to position the Company to deliver value to shareholders and an improved performance in the current year is in prospect.

John GreenChairman29 July 2009

  CONSOLIDATED INCOME STATEMENT

Year ended

 31 March 2009

Year ended

 31 March 2008

Notes

£

£

£

£

Revenue

1

5,425,021

5,337,254

Cost of sales

1

(829,309

)

(1,481,062 

)

Gross profit

1

4,595,712

3,856,192

Other income

1

40,292

43,929

General administrative expenses

5,266,455

4,345,996

Impairment of goodwill

7

2,624,387

Impairment of intangible assets

8

646,700

Amortisation of intangible assets

8

120,000

60,000

Revaluation of trading investments 

9

381,636

72,704

Loss on disposal of trading investments

14,840

-

Impairment of available-for-sale investments

2

-

93,567

Non-recurring items and AIM admission expenses

286,790

399,047

(9,340,808

)

(4,971,314

)

Operating loss

(4,704,804

)

(1,071,193

)

Investment revenues

3

147,119

416,423

Finance costs

3

(19,140

)

(120,380

)

Loss on disposal of available-for-sale investments

-

(3,333

)

Loss before taxation

(4,576,825

)

(778,483

)

Taxation

108,433

42,836

Loss for the year attributable to equity holders of the Company

(4,468,392

)

(735,647

)

Earnings per share

Basic and diluted

6

(10.63p

)

(2.97p

)

The loss for the year attributable to equity holders of the Company is as follows:

Loss before tax, goodwill impairment, revaluation of investments and non-recurring items

(502,472

)

(153,165

)

Impairment of goodwill

2,624,387

-

Impairment of intangible assets 

646,700

-

Amortisation of intangible assets

120,000

60,000

Revaluation of investments held for sale

381,636

72,704

Loss on disposal of investments held for sale

14,840

-

Impairment of available-for-sale investments

-

93,567

Non-recurring items

286,790

399,047

(4,074,353

)

(625,318

)

(4,576,825

)

(778,483

)

Taxation

108,433

42,836

(4,468,392

)

(735,647

)

No dividends were paid during the year (2008: £Nil).

  CONSOLIDATED BALANCE SHEET

as at 31 March 2009

2009

2008

Notes

£

£

£

£

Non-current assets

Goodwill

7

2,554,000

5,127,860

Intangible assets

8

562,300

1,329,000

Property, plant and equipment

274,543

385,762

Available-for-sale investments

-

49,569

Trade and other receivables

10

150,000

150,000

3,540,843

7,042,191

Current assets

Trade and other receivables

10

1,026,848

3,085,655

Trading investments

-

346,636

Cash and cash equivalents

11

2,152,932

1,793,344

3,179,780

5,225,635

Current liabilities

Trade and other payables

12

(726,129)

(3,367,473)

Current tax liabilities

-

(45,678)

(726,129)

(3,413,151)

Net current assets

2,453,651

1,812,484

Non-current liabilities

Deferred tax liabilities

(16,000

)

(34,579

)

Total assets less liabilities

5,978,494

8,820,096

Equity

Share capital

13

3,272,227

3,114,727

Share premium account

11,705,061

10,340,169

Other reserves

(3,845,350

)

(3,845,350

)

Revaluation reserve

-

35,690

Share-based payment reserve

14

292,485

152,397

Retained earnings

(5,445,929

)

(977,537

)

Equity attributable to equity holders of the Company

5,978,494

8,820,096

  CONSOLIDATED CASH FLOW STATEMENT 

for the year ended 31 March 2009

2009

2008

£

£

Cash flows from operating activities

Cash used in operations

15

(1,087,287

)

(826,384

)

Interest received

3

147,119

416,423

Interest paid

3

(19,140

)

(120,380

)

Tax received/ (paid)

(91,613

)

(101,238

)

Net cash used in operating activities

(1,050,921

)

(631,579

)

Cash flows from investing activities

Acquisition of subsidiary business

(50,527

)

(1,064,080

)

Purchase of property, plant and equipment

(11,516

)

(139,180

)

Proceeds from disposal of held-for-sale investments

25,160

10,000

Purchase of held-for-sale investments

(75,000

)

-

Net cash used in investing activities

(111,883

)

(1,193,260

)

Cash flows from financing activities

Proceeds from issue of shares (net of issue costs)

1,522,392

1,504,545

Net cash generated from financing activities

1,522,392

1,504,545

Net increase / (decrease) in cash and cash equivalents

359,588

(320,294

)

Cash and cash equivalents at beginning of year

1,793,344

2,113,638

Cash and cash equivalents at end of year

2,152,932

1,793,344

  CONSOLIDATED STATEMENT OF CHANGES IN EQUITY FOR THE YEAR ENDED 31 MARCH 2009

Share capital

Share premium

Other reserves

Revaluation reserve

Share based payment reserve

Retained earnings

£

£

£

£

£

£

Balance at 1 Apr 2007

1,942,000

7,408,351

(3,845,350

)

(41,235

)

64,066

(241,890

)

Proceeds from new share issue (net of issue costs)

1,172,727

2,931,818

-

-

-

-

Movement in revaluation of available for sale investments

-

-

-

76,925

-

-

Net loss for the year

-

-

-

-

-

(735,647

)

Total recognised income and expenses

1,172,727

2,931,818

-

76,925

-

(735,647

)

Recognition of share-based payments

-

-

-

-

88,331

-

Balance at 31 Mar 2008

3,114,727

10,340,169

(3,845,350

)

35,690

152,397

(977,537

)

Proceeds from new share issue (net of issue costs)

157,500

1,364,892

-

-

-

-

Movement in revaluation of available for sale investments

-

-

-

(35,690

)

-

-

Net loss for the year

-

-

-

-

-

(4,468,392

)

-

Total recognised income and expenses

157,500

1,364,892

-

(35,690

)

-

(4,468,392

)

Recognition of share-based payments

-

-

-

-

140,088

-

Balance at 31 Mar 2009

3,272,227

11,705,061

(3,845,350

)

-

292,485

(5,445,929

)

  NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS 

1. REVENUE AND GROSS PROFIT BY SEGMENT

The Group's results for the year ended 31 March 2009, all of which were generated within the United Kingdomcan be analysed by product as follows:

Private client and institutional broking

£

Corporate finance and private equity

£

Unallocated and reconciling items

£

TOTAL 2009

£

Revenue

3,595,208

1,829,813

-

5,425,021

Cost of sales

(708,255

)

(121,054

)

-

(829,309

)

Gross profit

2,886,953

1,708,759

-

4,595,712

Other income

29,776

8,411

2,105

40,292

Administrative expenses

(2,847,587

)

(2,370,893

)

(45,974

)

(5,264,454

)

Impairment of goodwill

(1,180,015

)

(1,444,372

)

-

(2,624,387

)

Impairment of intangible assets

-

(646,700

)

-

(646,700

)

Amortisation of intangible assets

-

(120,000

)

-

(120,000

)

Revaluation of trading investments

-

(67,747

)

(313,889

)

(381,636

)

Loss on disposal of trading investments

-

(14,840

)

-

(14,840

)

Non-recurring costs

(121,931

)

(30,100

)

(134,759

)

(286,790

)

Operating (loss) / profit

(1,232,804

)

(2,977,482

)

(492,517

)

(4,702,803

)

Investment revenues

81,885

33,319

31,915

147,119

Finance costs

(18,952

)

-

(188

)

(19,140

)

Loss on disposal of fixed assets

-

(2,001

)

-

(2,001

)

 (Loss) / profit before taxation

(1,169,871

)

(2,946,164

)

(460,790

)

(4,576,825

)

Taxation

-

90,903

17,530

108,433

(Loss) / profit after taxation

(1,169,871

)

(2,855,261

)

(443,260

)

(4,468,392

)

Other information

Capital additions (including those resulting from acquisition) 

8,674

2,842

-

11,516

Share based payments

30,571

46,146

63,371

140,088

Depreciation

41,548

79,186

-

120,734

Balance sheet

Assets

2,125,175

2,055,642

2,539,806

6,720,623

Liabilities

(139,684

)

(280,191

)

(322,254

)

(742,129

)

  NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

The Group's results for the year ended 31 March 2008, all of which were generated within the United Kingdomcan be analysed by product as follows:

Private client and institutional 

broking

£

Corporate finance and private equity

£

Unallocated and reconciling items

£

TOTAL 2008

£

Revenue

3,027,287

2,309,967

-

5,337,254

Cost of sales

(890,393

)

(590,669

)

-

(1,481,062

)

Gross profit

2,136,894

1,719,298

-

3,856,192

Other income

20,000

23,929

-

43,929

2,156,894

1,743,227

-

3,900,121

Administrative expenses

(2,116,181

)

(1,367,463

)

(862,352

)

(4,345,996

)

Amortisation of intangible assets

-

(60,000

)

-

(60,000

)

Revaluation of trading investments

-

(72,704

)

-

(72,704

)

Impairment of trading investments

-

-

(93,567

)

(93,567

)

Other non-recurring costs

-

-

(399,047

)

(399,047

)

Operating (loss) / profit

40,713

243,060

(1,354,966

)

(1,071,193

)

Investment revenues

-

-

416,423

416,423

Finance costs

-

-

(120,380

)

(120,380

)

Loss on disposal of available-for-sale investments

-

-

(3,333

)

(3,333

)

(Loss) / profit before taxation

40,713

243,060

(1,062,256

)

(778,483

)

Taxation 

-

-

42,836

42,836

(Loss) / profit after taxation

40,713

243,060

(1,019,420

)

(735,647

)

Other information

Capital additions (including those resulting from acquisition)

134,256

261,848

4,924

401,028

Share based payments

-

-

117,397

117,397

Depreciation

11,842

37,201

40,580

89,623

Balance sheet

Assets

2,949,891

3,687,213

5,630,722

12,267,826

Liabilities

2,187,302

556,378

704,050 

3,447,730

  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

2. PARTICULAR ADMINISTRATIVE EXPENSES

The Group has disclosed separately the following items, due to their material effect on the accounts:

Notes

2009

£

2008

£

Impairment of goodwill

2,624,387

-

Impairment of intangibles

646,700

-

Amortisation of intangibles

120,000

60,000

Impairment of trading investments

381,636

72,704

Disposal of trading investments

14,840

-

One-off professional costs

84,568

253,000

Severance payments

155,472

95,233

Recruitment costs

-

50,814

Impairment of available-for-sale investment

-

93,567

Bad debts written-off

46,750

-

4,074,353

625,318

3. INVESTMENT REVENUE AND FINANCE COSTS

Investment revenues comprise:

2009

£

2008

£

Interest receivable in respect of client bank accounts

27,635

332,858

Interest receivable in respect of Group company bank accounts

64,840

52,777

Other interest receivable

54,644

30,788

147,119

416,423

Finance costs comprise:

2009

£

2008

£

Interest payable to clients

18,952

120,067

Interest on bank overdrafts

-

3

Other interest 

188

310

19,140

120,380

4. LOSS FOR THE YEAR

The loss for the year is stated after charging:

2009

£

2008

£

Auditors' remuneration - auditing of accounts pursuant to legislation

25,000

81,500

Auditors' remuneration - other services relating to taxation

-

9,185

Auditors' remuneration - other services

-

21,502

Operating leases - land and buildings

206,480

165,208

Operating leases - machinery

27,748

19,718

Depreciation of property, plant and equipment

120,734

89,164

Impairment of goodwill

2,624,387

-

Amortisation of intangible assets

120,000

60,000

Impairment of intangible assets

646,700

-

Share-based payments

140,088

117,397

  NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

5. STAFF COSTS

Directors' remuneration

2009

£

2008

£

Aggregate emoluments (excluding pension contributions)

374,374

599,844

Highest paid director (included within the above)

128,057

191,600

The number of directors for whom retirement benefits are accruing under money purchase pension schemes amounted to 1 (2008: 1). During the year £25,873 (2008 £12,894) was paid into such schemes by the Group in respect of the director.

The following non-salary expenses were incurred in respect of directors:

Compensation

2009

£

2008

£

Short-term benefits (health care, dental care and subsidised gym membership) 

9,291

6,877

Long-term benefits (life assurance, critical illness cover and income protection)

4,876

-

Share based payments

6,642

13,932

20,809

20,809

All key management personnel remuneration is included above. Note that short-term benefits are included in the amounts shown above for directors' remuneration.

Staff costs (including directors' remuneration)

2009

£

2008

£

Wages and salaries (including commission and bonuses)

3,062,608

2,531,385

Social security costs

358,934

359,742

Termination payments - directors

52,500

70,100

Termination payments - other

102,972

20,000

3,577,014

2,981,227

Staff numbers

2009

2008

Number

Number

Executive directors 

5

5

Others

38

33

The average number of employees (including directors) during the year was:

43

38

Pension contributions

During the year an expense of £108,796 (2008 £57,432) was recorded in the Consolidated Income Statement in respect of retirement benefits for staff (including directors) accruing under money purchase pension schemes.

  NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

6. EARNINGS PER SHARE

Basic earnings per share are based on the post-tax loss for the year of £4,468,392 (2008: loss of £735,647) and on 42,021,243 ordinary 1p shares (2008: 24,757,165) being the weighted average number of shares in issue during the year.

The effect of all potential ordinary shares under option is anti-dilutive. Details of the share options issued which could be dilutive in the future are set out in note 14.

Calculations are as follows: 

Earnings for the purpose of basic and diluted earnings per share

2009

£

2008

£

Net loss attributable to equity holders of MSPLC

(4,468,392

)

(735,647

)

Impairment of goodwill

2,624,387

Amortisation / Impairment of intangible assets 

766,700

60,000

Revaluation of investments held-for-sale

381,636

72,704

Loss and disposal of investments held-for-sale

14,840

-

Impairment of available-for-sale investments

-

93,567

Non-recurring costs

286,790

399,047

Expenses added back

4,074,353

625,318

Notional net loss after adding back above expenses

(394,039

)

(110,329

)

Number of shares

Weighted average number of ordinary shares for the purpose of calculating basic earnings per share 

42,021,243

24,757,165

Weighted average number of ordinary shares for the purpose of calculating diluted earnings per share

47,220,057

29,230,411

Earnings per share (EPS)

Basic and diluted EPS based on loss attributable to equity holders

(10.63p

)

(2.97p

)

Basic EPS after adding back above expenses

(0.94p

)

(0.45p

)

Diluted EPS after adding back above expenses

(0.94p

)

(0.45p

)

  NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

7. GOODWILL

2009

2008

Cost

£

£

At 1 April

5,549,901

3,130,056

Recognised on acquisition of MSGL

-

-

Recognised on reverse acquisition of MSPLC

-

-

Recognised on acquisition of JEP

50,527

2,419,845

At 31 March 

5,600,428

5,549,901

Impairment

At 1 April

422,041

422,041

Charge for the year

2,624,387

-

At 31 March 

3,046,428

422,041

Net Book Value

At 31 March

2,554,000

5,127,860

Goodwill acquired in a business combination is allocated to the cash generating units expected to benefit from the business combination. The Group tests goodwill annually for impairment or more frequently if deemed necessary.

The carrying amount of the segments has been reduced to their recoverable amount through recognition of an impairment loss against goodwill (refer note 4). The impairment charge has arisen due to the change in market conditions during the year. This charge has been included in the income statement.

Impairment tests for goodwill

Goodwill is allocated to the group's cash-generating units (CGUs) identified according to operating segment.

The recoverable amount of a CGU is determined based on value-in-use calculations. These calculations use pre-tax cash flow projections based on financial budgets approved by management covering a five-year period. A discount rate of 9% per annum has been assumed throughout the period.

  NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

8. INTANGIBLE ASSETS

 

 

 
 
 
2009
 
2008
Cost
 
 
 
£
 
£
At 1 April
 
 
 
1,389,000
 
-
Recognised on acquisition of JEP
 
 
 
-
 
1,389,000
 
 
 
 
 
 
 
At 31 March
 
 
 
1,389,000
 
1,389,000
 
 
 
 
 
 
 
Amortisation
 
 
 
 
 
 
At 1 April
 
 
 
60,000
 
-
Charge for the year
 
 
 
120,000
 
60,000
 
 
 
 
 
 
 
At 31 March
 
 
 
180,000
 
60,000
 
 
 
 
 
 
 
Impairment
 
 
 
 
 
 
At 1 April
 
 
 
-
 
-
Impairment Charge
 
 
 
646,700
 
-
 
 
 
 
 
 
 
At 31 March
 
 
 
646,700
 
-
 
 
 
 
 
 
 
Net Book Value
 
 
 
 
 
 
At 31 March
 
 
 
562,300
 
1,329,000
 
 
 
 
 
 
 

Intangible assets represent externally acquired trademarks, customer relationships and non-compete agreements arising from the acquisition of JEP in October 2007.

Impairment tests for intangible assets

The Group has reviewed the carrying value of intangible assets in relation to trademarks and customer relationships acquired in the light of the change in market conditions and transaction volumes and has determined that it would be prudent to write down the carrying value of its intangible assets by £646,700. This charge has been included in the income statement.

  NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

9. INVESTMENTS

Non-current investments

2009

£

2008

£

Investments available for sale at start of year at cost

133,667

133,667

IFRS revaluation adjustment brought forward

(84,098

)

(58,907

)

Investments available for sale at start of year at fair value

49,569

)

74,760

Disposal of investments

-

-

Investmentacquired 

-

-

Revaluation at year end

(49,569

)

(25,191

)

At 31 March 

-

49,569

The Group holds a number of warrants and options over shares in various companies, some unlisted, and others listed on AIM. The reduction of £35,690 in the fair value of these options during the year has been posted to the revaluation reserve.  The cost of these options and warrants was £Nil. Fair value has been established by calculating the difference between the market value of the shares and the exercise price. Market value has been ascertained by reference to the market price in the case of options over shares in listed companies, or otherwise by use of other appropriate valuation techniques.

Trading investments (also known as "held for sale" investments or assets) represent investments in listed equities which present the Group with the opportunity to receive dividend income and make trading gains.

Current investments

2009

£

2008

£

Investments held for sale at start of year at fair value

346,636

390,000

Disposal of investments

(40,000

)

(13,333

)

Investmentacquired at fair value 

75,000

42,673

Revaluation of investments at year end

(381,636

)

(72,704

)

Fair value of investments held for sale at end of year

-

346,636

The movement in fair value has been included in the Consolidated Income Statement.

The market value of the investments at 31 March 2009 was £150,732.

10. TRADE AND OTHER RECEIVABLES

Amounts falling due within one year

2009

£

2008

£

Receivable from clients

-

1,806,819

Less provision for impairment of receivables from clients

-

(20,000

)

Receivable from counterparties 

391,870

521,951

Less provision for impairment of receivables from counterparties

(117,674

)

(121,872

)

Other receivables

63,445

24,058

Prepayments and accrued income

539,539

874,699

Corporation tax receivable

149,668

-

1,026,848

3,085,655

Within trade and other receivables the largest debtor represents 14% of the amounts outstanding at the balance sheet date. The maximum exposure to credit risk from trade and other receivables is represented by the above amounts. The Group has a policy of treating all receivables which are more than 90 days overdue as impaired.

Amounts falling due after more than one year

2009

£

2008

£

Other receivables

150,000

150,000

150,000

150,000

The directors consider that the above amounts are stated at their fair value.

  NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

11. CASH AND CASH EQUIVALENTS

Cash and cash equivalents consist of the Group's own cash at bank only. MSGL no longer holds client funds. At the previous year end MSGL held money on behalf of clients in trust in sterling and in various foreign currencies, in accordance with the client money regulations of the FSA.  As these balances, as well as the associated market risk, belonged to MSGL's clients, the balances were excluded from the Consolidated Balance Sheet.

As at the balance sheet date, the following client money balances were held:

2009

£

2008

£

Sterling

-

4,934,857

US dollars

-

350,350

Euros

-

112,827

Swiss francs

-

6,186

Canadian Dollars

-

12,412

-

5,416,632

12. TRADE AND OTHER PAYABLES

2009

£

2008

£

Amounts owed to clients and other counterparties

218,780

2,142,289

Other taxes and social security

124,398

210,385

Accruals and deferred income

241,742

880,085

Other payables

141,209

134,714

726,129

3,367,473

The directors consider that the above amounts are stated at their fair value.

All trade and other payables are unsecured and repayable on demand/at short notice.

The group has a policy of paying creditors as they fall due in accordance with the credit terms of its suppliers.

13. CALLED UP SHARE CAPITAL

2009

£

2008

£

Authorised

50,000,000 1p New Ordinary shares (2008 - 50,000,000 10p ordinary shares)

500,000

5,000,000

50,000,000 9Deferred shares (2008 - Nil)

4,500,000

-

5,000,000

5,000,000

Called up, allotted and fully paid

46,897,270 1p New Ordinary shares (2008 - 31,147,270 10p Ordinary shares)

468,973

3,114,727

31,147,270 9Deferred shares

2,803,254

-

3,272,227

3,114,727

The authorised share capital of MSPLC at 1 April 2008 was 50,000,000 shares of 10 pence each (£5,000,000), of which 31,147,270 (£3,114,727) were in issue. On 22 July 2008, the Company undertook a capital reorganisation which split each existing 10p ordinary share into a 1p New Ordinary share plus a 9p Deferred share. In addition the Company placed 15,750,000 New Ordinary shares of 1p each at 10 pence per share. The Deferred shares have no voting rights nor any entitlement to any dividends nor to attend general meetings. The Board intends to apply to the High Court at the appropriate time for the Deferred shares to be cancelled.

   NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

14. SHARE BASED PAYMENTS

The Group runs two equity-settled share based option schemes, an Enterprise Management Incentives ("EMI") scheme and an Executive Share Option Scheme ("EXSOS"). Options expire if the director or employee leaves the Group before exercise or if the options remain unexercised after the exercise period has lapsed.

The Group recognised total expenses of £140,088 (£117,397) related to equity-settled share based payment transactions. The corresponding equity credit has been allocated to the share-based payment reserve. No deferred tax charge or credit has been recognised (2008: deferred tax charge £6,588).

At 31 March 2009 the following options have been granted and remain outstanding in respect of ordinary shares of 1p in the Company under the Company's EMI scheme.

Dates of grant

20 November 2008

24 August 2007 - 9 October 2007

30 June 2006 - 30 October 2006

Exercisable two years following date of grant

23 April 2010 -

19 November 2018

24 August 2009 -

 8 October 2017

30 June 2008 - 29 October 2016

Number of shares

1,516,083

1,199,004

1,469,603

Exercise price per share

15.00p - 25.00p

35.00p-36.50p

29.94p

Fair value per share

0.83p - 1.15p

8.41p - 8.83p

0.5p-23.56p

The fair value of the options has been calculated using the Black-Scholes model with the following inputs. Expected volatility is based on the historical share price volatility.

Share price at date of grant

7.00p

36.50p - 38.50p

14.97p-50.00p

Expected life

2.5 years

2.5 years

2.18 - 2.5 years 

Expected volatility

67.4%

29.9%

29.9%

Risk free rate

3.62%

4.08% - 4.68%

4.68%

Expected dividend yield

Nil

Nil

Nil

The following table reconciles outstanding share options at the beginning and end of the financial year.

2009

2008

EMI Share option scheme

Number of shares

Weighted average exercise price

Number of shares

Weighted average exercise price

1 April

4,129,109

31.36p

2,246,160

29.94p

Granted

1,421,083

18.11p

2,142,719

32.79p

Exercised

-

-

Forfeited

(1,365,502

)

27.51p

(259,770

)

30.98p

31 March

4,184,690

28.11p

4,129,109

31.36p

Exercisable

1,469,603

29.94p

-

  NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

14. SHARE BASED PAYMENTS (continued)

At 31 March 2009 the following options have been granted and remain outstanding in respect of ordinary shares of 1p in the Company under the Company's EXSOS scheme.

Dates of grant

24 August 2007 - 9 October 2007

30 June 2006

Exercisable two years following date of grant

24 August 2009 - 8 October 2017

30 June 2008 - 29 June 2016

Number of shares

549,426

501,047

Exercise price per share

35.00p-36.50p

29.94p

Fair value per share

8.41p- 8.83p

0.5p

The fair value of the options has been calculated using the Black-Scholes model with the following inputs. Expected volatility is based on the historical share price volatility.

Share price at date of grant

36.50p-38.50p

14.97p

Expected life

2.5 years

2.5 years 

Expected volatility

29.9%

29.9%

Risk free rate

4.08% - 4.57%

4.68%

Expected dividend yield

Nil

Nil

The following table reconciles outstanding share options at the beginning and end of the financial year.

2009

2008

EXSOS Share option scheme

Number of shares

Weighted average exercise price

Number of shares

Weighted average exercise price

1 April

1,356,339

33.08p

668,063

29.94p

Granted

-

688,276

36.13p

Exercised

-

-

Forfeited

(305,866

)

32.92p

 

-

31 March

1,050,473

33.13p

1,356,339

33.08p

Exercisable

501,047

29.94p

-

15. CASH GENERATED FROM OPERATIONS

Year ended

Year ended

31 March 2009

£

31 March 2008

£

Operating loss for the year

(4,704,804

)

(1,071,193

Adjustments for:

Depreciation

120,734

89,623

Impairment of goodwill

2,624,387

-

Amortisation of intangible assets

120,000

60,000

Impairment of intangible assets

646,700

-

Revaluation of investments held for sale

381,636

72,704

Loss on sale of investments held-for-sale

14,840

3,333

Loss on disposal of property, plant and equipment

2,001

-

Impairment of available for sale investments

-

93,567

Share based payment expense

140,088

117,397

Changes in working capital:

(Increase) / decrease in receivables

2,208,475

(59,112

(Decrease) / increase in payables

(2,641,344

)

(132,703

Net cash outflow from operating activities

(1,087,287

)

(826,384

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR CKCKDFBKDNOB
Date   Source Headline
10th May 20249:37 amRNSTransaction in Own Shares
9th May 20249:24 amRNSTransaction in Own Shares
8th May 20249:56 amRNSTransaction in Own Shares
7th May 202411:41 amRNSTransaction in Own Shares
3rd May 20249:44 amRNSTransaction in Own Shares
26th Apr 202410:00 amRNSTransaction in Own Shares
25th Apr 20249:29 amRNSTransaction in Own Shares
24th Apr 20249:41 amRNSTransaction in Own Shares
23rd Apr 20249:34 amRNSTransaction in Own Shares
22nd Apr 20249:43 amRNSTransaction in Own Shares
17th Apr 20249:23 amRNSTransaction in Own Shares
16th Apr 20249:44 amRNSTransaction in Own Shares
15th Apr 20249:12 amRNSTransaction in Own Shares
12th Apr 20249:43 amRNSTransaction in Own Shares
11th Apr 20249:35 amRNSTransaction in Own Shares
10th Apr 202411:34 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSYear end trading summary and date of results
9th Apr 20249:38 amRNSTransaction in Own Shares
5th Apr 20249:25 amRNSTransaction in Own Shares
4th Apr 20249:33 amRNSTransaction in Own Shares
3rd Apr 20249:22 amRNSTransaction in Own Shares
28th Mar 202411:41 amRNSTransaction in Own Shares
27th Mar 20249:57 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSGrant and variation of Options
26th Mar 202410:31 amRNSTransaction in Own Shares
25th Mar 202412:24 pmRNSTransaction in Own Shares
22nd Mar 20249:01 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSDirector/PDMR Dealings
21st Mar 20249:14 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSMercia secures two further BBB contracts
20th Mar 20249:32 amRNSTransaction in Own Shares
18th Mar 20249:59 amRNSTransaction in Own Shares
15th Mar 20249:04 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSMercia completes three syndicated funding rounds
13th Mar 202411:24 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSMercia's Northern VCTs raise £60.0million
12th Mar 20249:46 amRNSTransaction in Own Shares
11th Mar 20249:16 amRNSTransaction in Own Shares
8th Mar 202410:14 amRNSTransaction in Own Shares
7th Mar 202410:15 amRNSTransaction in Own Shares
5th Mar 202410:16 amRNSTransaction in Own Shares
4th Mar 20249:44 amRNSTransaction in Own Shares
1st Mar 202410:11 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSNew British Business Bank contracts
28th Feb 20248:38 amRNSTransaction in Own Shares
27th Feb 20248:44 amRNSTransaction in Own Shares
26th Feb 20248:49 amRNSTransaction in Own Shares
23rd Feb 20249:25 amRNSTransaction in Own Shares
21st Feb 20249:29 amRNSTransaction in Own Shares
16th Feb 20248:59 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.